MARATTO

article · Bulletin du Cancer

Aplasies médullaires sévères acquises dans les pays émergents : prise en charge dès l’indication de l’allogreffe de cellules souches hématopoïétiques jusqu’au suivi postgreffe (SFGM-TC)

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • Acute Myeloid Leukemia Research
  • Hematopoietic Stem Cell Transplantation
  • Myeloproliferative Neoplasms: Diagnosis and Treatment

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.bulcan.2024.07.008

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.